Henning Gronbaek Selected Research

Lipopolysaccharides

1/2019

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henning Gronbaek Research Topics

Disease

7	Fibrosis (Cirrhosis) 01/2023 - 01/2017
4	Hemorrhage 01/2023 - 01/2019
4	Neoplasms (Cancer) 01/2022 - 01/2021
4	Inflammation (Inflammations) 12/2021 - 01/2017
4	Acute-On-Chronic Liver Failure 12/2021 - 01/2017
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2021
2	Hepatic Encephalopathy 01/2023 - 01/2019
2	Kidney Neoplasms (Kidney Cancer) 03/2022 - 01/2021
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2021
2	Infections 01/2021 - 01/2020
2	Liver Failure 01/2018 - 01/2018
1	Fatty Liver 01/2023
1	Colonic Neoplasms (Colon Cancer) 03/2022
1	Rectal Neoplasms (Rectal Cancer) 03/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Liver Diseases (Liver Disease) 12/2021
1	Portal Hypertension 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2020
1	Obesity 11/2020
1	Peritonitis 01/2020
1	Autoimmune Hepatitis 01/2020
1	Cross Infection (Nosocomial Infection) 01/2020
1	Sclerosing Cholangitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Necrosis 01/2020
1	Ascites 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Ketosis 01/2019
1	Alcoholic Hepatitis 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2012
1	Flushing 01/2012
1	Diarrhea 01/2012
1	Varicose Veins (Varicose Vein) 08/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2004

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2018
2	Collagen Type III (Type III Collagen)IBA 10/2022 - 12/2021
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	CytokinesIBA 01/2019 - 01/2017
1	Keratin-18 (Keratin 18)IBA 01/2023
1	Collagen Type VIIBA 10/2022
1	Complement C3 (C3 Complement)IBA 10/2022
1	Peptide Receptors (Peptide Receptor)IBA 10/2022
1	Radioisotopes (Radionuclides)IBA 10/2022
1	insulin receptor-related receptor (IRR)IBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	CollagenIBA 12/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Mannose ReceptorIBA 01/2021
1	AlbuminsIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2019
1	KynurenineIBA 01/2019
1	LipidsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Quinolinic AcidsIBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2018
1	BilirubinIBA 01/2018
1	Urea (Carbamide)FDA LinkGeneric 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2018
1	ChemokinesIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	NucleotidesIBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	Chromogranin AIBA 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2004
1	Growth Hormone (Somatotropin)IBA 01/2004
1	Insulin-Like PeptidesIBA 01/2004

Therapy/Procedure

3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023 - 11/2020
2	Transjugular Intrahepatic Portasystemic Shunt 01/2023 - 01/2019
2	Therapeutics 10/2022 - 08/2007
1	Contraindications 01/2023
1	Antibiotic Prophylaxis 01/2021